Angioplasty Balloons Market Analysis By Type (Normal Balloons, Drug Eluting Balloons, Cutting Balloons, Scoring Balloons), By Application (Peripheral, Coronary), By End Use, By Region, And Segment Forecasts, 2013 - 2024

The global angioplasty balloon market is expected to reach a value of USD 2.9 billion by 2024, according on a new report by Grand View Research, Inc. The growth of the market is attributed to favorable government policies, approval & commercialization of several angioplasty balloons, and increasing coronary & peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients and surgeons prefer this procedure over high cost stent placements.

Furthermore, advancements in the angioplasty balloons are likely to propel the market. For instance, in December 2014 Medtronic plc received a U.S.FDA approval for their drug coated balloon IN. PACT Admiral for the treatment of peripheral artery disease. Approval and commercialization of cutting and scoring balloons, such as Flextome, AngioSculpt, TREK and MINI TREK balloon, rising adoption of new balloons, and lower cost as compared to stent placement are likely to drive the market during the forecast period.

Further Key Findings From the Study Suggest:

Normal balloon segment dominated the market in 2015 due to low cost and favorable U.S. FDA policies. Its ability to treat coronary artery obstruction is further expected to propel the market growth.

Drug-eluting balloon segment is anticipated to be the most lucrative during the forecast period. This is attributed to increasing investment in R & D by major players and lower restenosis rates.

Coronary balloon dominated in 2015 and is expected to maintain its dominance during forecast period. This is due to rising incidence rate of coronary artery diseases around the globe.

Peripheral is the most lucrative segment owing to launching of new peripheral products in recent years. Market players are in a process of introducing newer products with increased efficiency.

Ambulatory surgery centers dominated the end use segment in 2015. They accounted for the highest share of the vertical as they help minimize the medical expenses and hospital stay.

Regionally, North America dominated the market in 2015 and is expected to maintain its position during the forecast period due to local presence of major market players and high cost of devices as compared to other regions.

Asia Pacific is anticipated to be fastest growing segment during the forecast period due to rising healthcare expenditure, growing investment of key market players in the region, and high patient population.

Some of the market players operating in the industry are Abbott; Boston Scientific Corporation; Cardinal Health (Cordis); Cook Medical; C. R. Bard, Inc.; ENDOCOR GmbH; Medtronic; Spectranetics; and Johnson & Johnson.

Table of Content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Angioplasty Balloons Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Favorable government policies
3.1.1.2 Increasing adoption of new technologies
3.1.1.3 Growing patient population
3.1.2 Market restraint analysis
3.1.2.1 Advancement in drug and gene therapy
3.2 Penetration & Growth Prospects Mapping
3.3 Angioplasty Balloon Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
3.5 Angioplasty Balloon competitive scenario, 2015
3.5.1 Competitive landscape: Market position analysis (based on types, regional presence and strategic initiatives)
Chapter 4 Angioplasty Balloons Market Type Estimates & Trend Analysis
4.1 Global Angioplasty Balloon Market: Type Movement Analysis
4.2 Normal Balloons
4.2.1 Normal balloons market estimates and forecasts, 2013 - 2024 (USD Million)
4.3 Drug Eluting Balloons
4.3.1 Drug eluting balloons market estimates and forecasts, 2013 - 2024 (USD Million)
4.4 Cutting Balloons
4.4.1 Cutting balloons market estimates and forecasts, 2013 - 2024 (USD Million)
4.5 Scoring Balloons
4.5.1 Scoring balloons market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 5 Angioplasty Balloons Market Application Estimates & Trend Analysis
5.1 Global Angioplasty Balloons Market: Application Movement Analysis
5.2 Coronary
5.2.1 Coronary market estimates and forecasts, 2013 - 2024 (USD Million)
5.3 Peripheral
5.3.1 Peripheral market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 6 Angioplasty Balloons Market End Use Estimates & Trend Analysis
6.1 Global Angioplasty Balloons Market: End Use Movement Analysis
6.2 ASCs
6.2.1 ASCs market estimates and forecasts, 2013 - 2024 (USD Million)
6.3 Hospitals
6.3.1 Hospitals market estimates and forecasts, 2013 - 2024 (USD Million)
6.4 Cath Labs
6.4.1 Cath Labs market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 7 Angioplasty Balloons Market Regional Estimates & Trend Analysis
7.1 Regional Movement Analysis & Market Share, 2015 & 2024
7.2 North America
7.2.1 North America angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.2.2 North America angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.2.3 North America angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.2.4 U.S.
7.2.4.1 U.S. angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.2.4.2 U.S. angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.2.4.3 U.S. angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.2.5 Canada
7.2.5.1 Canada angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.2.5.2 Canada angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.2.5.3 Canada angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.3 Europe
7.3.1 Europe angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.3.2 Europe angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.3.3 Europe angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.3.4 Germany
7.3.4.1 Germany angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.3.4.2 Germany angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.3.4.3 Germany angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.3.5 UK
7.3.5.1 U.K angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.3.5.2 U.K. angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.3.5.3 U.K. angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.4.2 Asia Pacific angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.4.3 Asia Pacific angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.4.4 Japan
7.4.4.1 Japan angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.4.4.2 Japan angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.4.4.3 Japan angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.4.5 China
7.4.5.1 China angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.4.5.2 China angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.4.5.3 China angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.5 Latin America
7.5.1 Latin America angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.5.2 Latin America angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.5.3 Latin America angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.5.4 Brazil
7.5.4.1 Brazil angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.5.4.2 Brazil angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.5.4.3 Brazil angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.5.5 Mexico
7.5.5.1 Mexico angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.5.5.2 Mexico angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.5.5.3 Mexico angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.6 MEA
7.6.1 MEA angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.6.2 MEA angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.6.3 MEA angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
7.6.4 South Africa
7.6.4.1 South Africa angioplasty balloons market, by type, 2013 - 2024 (USD Million)
7.6.4.2 South Africa angioplasty balloons market, by application, 2013 - 2024 (USD Million)
7.6.4.3 South Africa angioplasty balloons market, by end use, 2013 - 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Medtronic
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Boston Scientific Corporation
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 Johnson & Johnson
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Abbott
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 C. R. Bard, Inc.
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 Cardinal Health (Cordis)
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic Initiatives
8.7 Spectranetics
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 BIOTRONIK
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 COOK MEDICAL INC.
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.10 ENDOCOR GmbH
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
8.11 B. Braun Melsungen AG
8.11.1 Company overview
8.11.2 Financial performance
8.11.3 Product benchmarking
8.11.4 Strategic initiatives